The score is held down primarily by weak financial performance (losses and negative operating/free cash flow) and a bearish technical setup (price below key moving averages with negative MACD). The debt-free balance sheet provides some stability, but valuation support is limited because earnings are negative and no dividend yield is available.
Positive Factors
Debt-free balance sheet
A debt-free capital structure materially lowers solvency and refinancing risk, giving the company durable financial flexibility. Over a multi-month horizon this permits funding working capital, absorbing cyclical losses or selectively investing in efficiency or product initiatives without near-term credit pressure.
Large equity base / low leverage
A sizeable equity cushion relative to assets acts as a structural buffer against earnings volatility and loss-absorption. This reduces the likelihood of insolvency, supports supplier and lender confidence, and lengthens the runway for operational recovery or strategic repositioning without forced asset sales.
Revenue growth and gross margin expansion
Top-line growth plus meaningful gross-margin improvement indicate underlying pricing, mix or input-cost relief that can be enduring. If sustained, these structural improvements provide a pathway to restore operating profitability and leverage fixed-cost base, improving long-term earnings potential.
Negative Factors
Negative operating and free cash flow
Multi-year negative operating and free cash flow is a structural weakness: it erodes liquidity and forces reliance on external financing or equity to fund operations. Persistent cash burn limits the firm's ability to invest in growth, sustain capex, or absorb shocks without dilutive or costly funding.
Deeply negative operating/EBITDA margins
Deeply negative operating and EBITDA margins signal structural cost or pricing issues that impair the firm's ability to convert revenue into sustainable profits. Even with revenue gains, margin collapse undermines return generation and requires fundamental operational or commercial fixes to restore viability.
Earnings volatility and negative ROE
Large swings in earnings and a negative ROE reduce predictability of future cash flows and impede capital-allocation planning. Equity erosion from losses can raise the firm’s effective cost of capital and constrain strategic initiatives, making sustained recovery more difficult without clear, durable profit improvement.
Pearl Polymers Limited (PEARLPOLY) vs. iShares MSCI India ETF (INDA)
Market Cap
₹266.16M
Dividend YieldN/A
Average Volume (3M)2.01K
Price to Earnings (P/E)―
Beta (1Y)0.97
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees64
SectorBasic Materials
Sector Strength58
IndustryPackaging & Containers
Share Statistics
EPS (TTM)-0.98
Shares Outstanding16,834,932
10 Day Avg. Volume3,097
30 Day Avg. Volume2,014
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.37
Price to Sales (P/S)2.08
P/FCF Ratio-8.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pearl Polymers Limited Business Overview & Revenue Model
Company DescriptionPearl Polymers Limited manufactures and trades in PET jars and bottles in India and internationally. The company offers jars and bottles for kitchen, home, and office use, as well as containers; and stainless steel and copper bottles. It also provides its products online. The company's packaging solutions are used for agro chemical, confectionery, cosmetics, food, liquor, and pharmaceutical products. Pearl Polymers Limited was incorporated in 1971 and is headquartered in New Delhi, India.
How the Company Makes Moneynull
Pearl Polymers Limited Financial Statement Overview
Summary
Despite a strong, debt-free balance sheet, FY2025 saw a sharp deterioration in profitability (net loss and deeply negative operating/EBITDA margins) and continued negative operating/free cash flow in FY2024–FY2025, indicating weak earnings quality and cash conversion.
Income Statement
28
Negative
Revenue improved in FY2025 (up ~5% YoY) and gross margin expanded meaningfully versus FY2024, signaling better pricing/mix or input-cost relief. However, profitability deteriorated sharply: FY2025 posted a sizable net loss with deeply negative operating and EBITDA margins, reversing FY2024’s modest profit. Longer-term results are volatile (large swings across years), which reduces confidence in earnings quality and sustainability.
Balance Sheet
74
Positive
The balance sheet is a clear strength: FY2025 shows no debt and a large equity base relative to assets, indicating low financial leverage and reduced solvency risk. That said, returns on equity turned negative in FY2025, reflecting weak profitability despite the conservative capital structure, and equity has come down from prior years, suggesting value erosion during loss periods.
Cash Flow
22
Negative
Cash generation is weak: operating cash flow and free cash flow were negative in FY2024 and FY2025, implying the business is consuming cash rather than funding itself internally. While free cash flow was negative alongside a net loss in FY2025 (and less negative than FY2024), the multi-year pattern shows material volatility, including a one-off very strong year (FY2022) that has not been sustained.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 21, 2026